Lola Koktysh[email protected]MRIQuantitative imaging biomarkers show promise for NASHQuantitative imaging biomarkers are a promising approach for evaluating normal biological or pathogenic processes, as well as response to treatment and intervention. One near-term clinical application is the assessment of nonalcoholic steatohepatitis (NASH), according to Lola Koktysh of ScienceSoft.March 6, 2017Page 1 of 1Top StoriesWomens ImagingImaging to have key role in new guidelines on managing mastitisMedical societies have issued guidelines on managing mastitis in women, including considerations for ultrasound and mammography.Digital X-RayCan radiologists, AI reliably identify lung abnormalities on x-ray?Womens ImagingModern EBRT reduces CVD risk in breast cancer patientsMolecular ImagingPET/CT metric improves outcome predictions in Pluvicto patientsSponsor ContentModernizing Radiotherapy Workflows
